Moderna
MRNA
#290
Rank
ยฃ60.31 B
Marketcap
ยฃ149.06
Share price
-2.17%
Change (1 day)
706.64%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -ยฃ2.29 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ2.21 Billion. In 2025 the company made an earning of -ยฃ2.11 Billion, an increase over its 2024 earnings that were of -ยฃ2.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ2.29 Billion8.47%
2025 -ยฃ2.11 Billion-23.03%
2024 -ยฃ2.74 Billion-8.22%
2023 -ยฃ2.99 Billion-140.65%
2022 ยฃ7.34 B-27.81%
2021 ยฃ10.16 B-1911.15%
2020 -ยฃ0.57 Billion44.7%
2019 -ยฃ0.39 Billion28.63%
2018 -ยฃ0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.31 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ9.66 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ5.13 B-320.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ36.26 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ89.94 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.93 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.93 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.13 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA